Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial (Q40047751)
Jump to navigation
Jump to search
scientific article published on 11 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial |
scientific article published on 11 September 2008 |
Statements
1 reference
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial (English)
1 reference
Frederik Barkhof
1 reference
Daniel D Mikol
1 reference
Peter Chang
1 reference
Patricia K Coyle
1 reference
Douglas R Jeffery
1 reference
Steven R Schwid
1 reference
Bettina Stubinski
1 reference
Bernard M J Uitdehaag
1 reference
REGARD study group
1 reference
11 September 2008
1 reference
1 reference
Identifiers
1 reference